Adma Biologics reported $31.72M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Adma Biologics USD 31.72M 11.2M Jun/2026
Alnylam Pharmaceuticals USD 108.02M 18.61M Jun/2026
BioCryst Pharmaceuticals USD 11.46M 501K Jun/2026
Minerva Neurosciences USD 640K 305K Dec/2025
Novavax USD 22.94M 6.84M Jun/2026
Omeros USD 8.84M 4.42M Jun/2025
Takeda JPY 446.78B 44.56B Jun/2026